AdaptHealth Corp. (AHCO)

Over the past six months, AdaptHealth's stock has experienced a decline, reaching $9 as of October 3, 2025, a 12.9% loss. Key events impacting the stock price include Q1 2025 earnings showing a decrease in net revenue and adjusted EBITDA, the divestiture of home infusion assets to reduce debt, Q2 2025 results with a decrease in net revenue and adjusted EBITDA, a partnership with a major national healthcare system, a director stock sale, and mixed analyst ratings.

AdaptHealth's stock has shown historical seasonal patterns, with October historically favoring a short bias. The company's "Respiratory Health" segment experienced strong demand earlier in 2025 due to a severe flu season. Demand for certain products, particularly respiratory equipment, can be influenced by seasonal health trends. AdaptHealth's services cater to an aging population and individuals with chronic conditions, which generally represent a consistent demand, but specific product lines may experience fluctuations.

AdaptHealth Corp. is a national provider of patient-centered, healthcare-at-home solutions, including home medical equipment (HME), medical supplies, and related services, operating within the Healthcare sector and the Medical Devices industry. The company provides essential medical equipment and supplies to patients in their homes, particularly those managing chronic conditions. Its major product and service offerings include sleep therapy solutions, diabetes management supplies, respiratory health equipment and services, and a broad range of home medical equipment and wellness at home products.

AdaptHealth has a significant national presence across the United States, serving patients annually in all 50 states through a network of approximately 660 to 700 locations in 47 states.

AdaptHealth generally receives positive feedback from customers, who commend the company for its helpful and courteous service, quality equipment, and efficient delivery. Customers have expressed satisfaction with the staff's care and assistance in selecting appropriate medical supplies. There is no readily available information detailing specific events that have negatively impacted AdaptHealth's brand reputation in the past year.

Institutional investors and hedge funds hold a significant portion of AdaptHealth's stock, owning 82.67% of the shares, while company insiders hold 1.55%. Major institutional owners have recently adjusted their positions, including Brooklyn Investment Group, Tower Research Capital LLC TRC, and AlphaQuest LLC. Director David Solomon Williams III sold shares in August 2025.